These included pancreatic cancer, prostate cancer, Hodgkin lymphoma, intracranial meningioma, mucin-producing pulmonary adenocarcinoma, gastric cancer and astrocytoma (Table 1). This evidence concerns the gene MUC5AC and prostate cancer.